NEW YORK (GenomeWeb) – Bio-Rad Laboratories has announced a partnership with Genetic Analysis, an Oslo, Norway-based clinical diagnostics firm focusing on the microbiome.

Under the terms of the agreement, Bio-Rad will make an equity investment in Genetic Analysis. In return, it will receive commercialization rights in certain undisclosed territories for Genetic Analysis' CE-marked GA-map technology to detect microbial imbalances, also known as gut dysbiosis, the firms said in a statement.

Financial and other details were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.